You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Recurrent medulloblastoma

Showing 1 - 25 of 7,895
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Medulloblastoma Trial in Houston (Treatment with MTX110)

Recruiting
  • Medulloblastoma
  • Treatment with MTX110
  • Houston, Texas
    The University of Texas Health Science Center at Houston
Jun 30, 2022

Recurrent Medulloblastoma Trial in Beijing (Apatinib Combined With Temozolomide and Etoposide Capsules)

Recruiting
  • Recurrent Medulloblastoma
  • Apatinib Combined With Temozolomide and Etoposide Capsules
  • Beijing, China
    Beijing Sanbo Brain Hospital
Feb 10, 2022

Recurrent Medulloblastoma, Recurrent Brain Tumor, Childhood, Malignant Glioma Trial in Durham (PEP-CMV)

Recruiting
  • Recurrent Medulloblastoma
  • +2 more
  • Durham, North Carolina
    Duke University Medical Center
Jan 8, 2022

Medulloblastoma, Neuroectodermal Tumor Trial in Los Angeles, Washington, Gainesville (TTRNA-xALT, TTRNA-DCs)

Active, not recruiting
Has Results
  • Medulloblastoma
  • Neuroectodermal Tumor
  • TTRNA-xALT
  • TTRNA-DCs
  • Los Angeles, California
  • +2 more
Jan 7, 2022

Brain Tumor, Brain Tumor, Recurrent, Brain Tumor, Refractory Trial in Memphis (Prexasertib, Cyclophosphamide, Gemcitabine)

Active, not recruiting
  • Brain Tumor
  • +12 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 20, 2022

High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Recurrent Medulloblastoma Trial in United States (PEP-CMV, Temozolomide,

Not yet recruiting
  • High Grade Glioma
  • +2 more
  • PEP-CMV
  • +2 more
  • Aurora, Colorado
  • +9 more
Jan 28, 2022

Diffuse Intrinsic Pontine Glioma, Recurrent Anaplastic Astrocytoma, Recurrent Glioblastoma Trial in Switzerland, United States

Active, not recruiting
  • Diffuse Intrinsic Pontine Glioma
  • +4 more
  • Los Angeles, California
  • +18 more
Aug 16, 2022

High Grade Glioma, Meningioma, Embryonal Tumor Trial in United States (LUTATHERA® (Lutetium Lu 177 dotatate))

Recruiting
  • High Grade Glioma
  • +12 more
  • LUTATHERA® (Lutetium Lu 177 dotatate)
  • Aurora, Colorado
  • +8 more
Jan 16, 2023

Medulloblastoma, Medulloblastoma, Childhood, Medulloblastoma Recurrent Trial in United States (Specialized Tumor Board Treatment

Recruiting
  • Medulloblastoma
  • +2 more
  • Specialized Tumor Board Treatment Plan
  • San Diego, California
  • +3 more
Dec 28, 2022

Solid Tumors, Neuroblastoma, Rhabdomyosarcoma Trial in Durham, Cincinnati (VAL-413, Temozolomide)

Recruiting
  • Solid Tumors
  • +5 more
  • Durham, North Carolina
  • +2 more
Jan 31, 2023

Medulloblastoma, Childhood Trial in Worldwide (177Lu-DTPA-omburtamab)

Terminated
  • Medulloblastoma, Childhood
  • Rochester, Minnesota
  • +9 more
Aug 15, 2022

Diffuse Intrinsic Pontine Glioma, Medulloblastoma, Childhood, Recurrent Trial in Madrid (AloCELYVIR)

Recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Medulloblastoma, Childhood, Recurrent
  • AloCELYVIR
  • Madrid, Spain
    Hospital Infantil Universitario Niño Jesús
Sep 29, 2022

Anaplastic Ependymoma, Atypical Teratoid/Rhabdoid Tumor, CNS Germ Cell Tumor Trial in Houston (drug, procedure, biological)

Recruiting
  • Anaplastic Ependymoma
  • +14 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 17, 2022

CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (EGFR806-specific chimeric antigen receptor (CAR) T cell)

Active, not recruiting
  • Central Nervous System Tumor, Pediatric
  • +8 more
  • EGFR806-specific chimeric antigen receptor (CAR) T cell
  • Seattle, Washington
    Seattle Children's Hospital
Jan 18, 2023

CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (HER2-specific chimeric antigen receptor (CAR) T cell)

Recruiting
  • Central Nervous System Tumor, Pediatric
  • +8 more
  • HER2-specific chimeric antigen receptor (CAR) T cell
  • Seattle, Washington
    Seattle Children's Hospital
Dec 14, 2022

Brain Tumor, Medulloblastoma, Brain Metastases Trial in Atlanta (WP1066)

Recruiting
  • Brain Tumor
  • +2 more
  • Atlanta, Georgia
    Children's Healthcare of Atlanta (CHOA)
Jul 24, 2022

Ependymoma, Glioblastoma, Medulloblastoma Trial in Duarte (IL13Ralpha2-specific Hinge-optimized 41BB-co-stimulatory CAR

Recruiting
  • Ependymoma
  • +3 more
  • IL13Ralpha2-specific Hinge-optimized 41BB-co-stimulatory CAR Truncated CD19-expressing Autologous T-Lymphocytes
  • Duarte, California
    City of Hope Medical Center
Mar 9, 2022

Childhood Astrocytoma, Childhood Atypical Teratoid/Rhabdoid Tumor, Diffuse Intrinsic Pontine Glioma Trial in Rochester

Active, not recruiting
  • Childhood Astrocytoma
  • +9 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Sep 8, 2022

Neuroblastoma, Medulloblastoma Trial in United States (TPI 287)

Terminated
Has Results
  • Neuroblastoma
  • Medulloblastoma
  • TPI 287
  • San Diego, California
  • +7 more
Apr 20, 2022

CNS Tumor, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma Trial in Seattle (SCRI-CARB7H3(s); B7H3-specific chimeric

Recruiting
  • Central Nervous System Tumor
  • +10 more
  • SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel
  • Seattle, Washington
    Seattle Children's Hospital
Dec 14, 2022

CNS Embryonal Tumor With Rhabdoid Features, CNS Embryonal Tumor, Not Otherwise Specified, CNS Ganglioneuroblastoma Trial in

Active, not recruiting
Has Results
  • Central Nervous System Embryonal Tumor With Rhabdoid Features
  • +14 more
  • Birmingham, Alabama
  • +23 more
Oct 7, 2022

CNS Embryonal Tumor, Embryonal Tumor With Multilayered Rosettes, C19MC-Altered, Germ Cell Tumor Trial in Minneapolis, Portland

Active, not recruiting
  • Central Nervous System Embryonal Neoplasm
  • +9 more
  • Minneapolis, Minnesota
  • +1 more
Oct 25, 2021

CNS Tumors, Medulloblastoma Trial in Worldwide (Pomalidomide)

Active, not recruiting
Has Results
  • Central Nervous System Neoplasms
  • Medulloblastoma
  • Stanford, California
  • +24 more
Sep 28, 2022

Ependymoma, Ewing Sarcoma, High-grade Glioma Trial in Worldwide (Nivolumab, NKTR-214)

Completed
  • Ependymoma
  • +9 more
  • Nivolumab
  • NKTR-214
  • Little Rock, Arkansas
  • +17 more
Dec 8, 2022

CNS Tumors, Glioblastoma, Gliosarcoma, Adult Trial run by the (ONC206)

Recruiting
  • Central Nervous System Neoplasms
  • +22 more
  • Bethesda, Maryland
    National Institutes of Health
Mar 1, 2022